Cargando…

Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma

BACKGROUND: Elucidation of epigenetic alterations in bladder cancer will lead to further understanding of the biology of the disease and hopefully improved therapies. Our aim was to perform an integrative epigenetic analysis of invasive urothelial carcinoma of the bladder to identify the epigenetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanford, Thomas, Meng, Maxwell V., Railkar, Reema, Agarwal, Piyush K., Porten, Sima P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809922/ https://www.ncbi.nlm.nih.gov/pubmed/29456764 http://dx.doi.org/10.1186/s13148-018-0451-x

Ejemplares similares

Molecular Analysis of Upper Tract and Bladder Urothelial Carcinoma: Results from a Microarray Comparison
por: Sanford, Thomas, et al.
Publicado: (2015)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Race modifies survival benefit of guideline‐based treatment: Implications for reducing disparities in muscle invasive bladder cancer
por: Washington, Samuel L., et al.
Publicado: (2020)

Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors
por: Lindquist, Karla J., et al.
Publicado: (2017)

Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions
por: Zuniga, Kyle B., et al.
Publicado: (2020)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
por: Siddiqui, Mohammad R., et al.
Publicado: (2019)

Rapidly Progressing Urothelial Carcinoma Due to a Rare TP53 (p.Arg110Pro) Mutation: A Case Report and Review of the Literature
por: Saoud, Ragheed, et al.
Publicado: (2021)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
por: Frydenlund, Noah, et al.
Publicado: (2018)

The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma
por: Raman, Jay D., et al.
Publicado: (2021)

Novel and emerging approaches in the management of non-muscle invasive urothelial carcinoma
por: Yassaie, Omid, et al.
Publicado: (2021)

Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
por: Maeda, Shingo, et al.
Publicado: (2022)

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans
por: Tsamouri, Maria Malvina, et al.
Publicado: (2021)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma
por: Basatac, Cem, et al.
Publicado: (2019)

Bioinformatic Identification of Potential Hub Genes in Muscle-Invasive Bladder Urothelial Carcinoma
por: Guo, Changgang, et al.
Publicado: (2020)

The clinicopathological characteristics of muscle‐invasive bladder recurrence in upper tract urothelial carcinoma
por: Shigeta, Keisuke, et al.
Publicado: (2021)

Muscle invasive urinary bladder urothelial carcinoma presenting with secondary nephrotic symptoms
por: Mizusawa, Hiroya, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
por: Renner, Alex, et al.
Publicado: (2021)

Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma
por: Fukushima, Hiroshi, et al.
Publicado: (2019)

Cost-Effectiveness of Immune Checkpoint Inhibitors in Urothelial Carcinoma—A Review
por: Walia, Arman S., et al.
Publicado: (2021)

IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype
por: Yang, Feiya, et al.
Publicado: (2019)

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma
por: Feng, Yueyi, et al.
Publicado: (2019)

Young age increases the risk of lymph-node metastasis in patients with muscle-invasive bladder urothelial carcinoma
por: Tian, Zijian, et al.
Publicado: (2020)

Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis
por: Bhat, Venkat, et al.
Publicado: (2018)

Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
por: Lee, Young H., et al.
Publicado: (2014)

Correction to: A comparison of stage-specific all-cause mortality between testicular sex cordstromal tumors and germ cell tumors: results from the National Cancer Database
por: Zuniga, Kyle B., et al.
Publicado: (2020)

A comparison of stage-specific all-cause mortality between testicular sex cord stromal tumors and germ cell tumors: results from the National Cancer Database
por: Zuniga, Kyle B., et al.
Publicado: (2020)

Gastrocnemius acrometastasis from muscle-invasive urothelial bladder carcinoma: A case report
por: Roslly, Mohd Zulkimi, et al.
Publicado: (2021)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma
por: Olkhov-Mitsel, Ekaterina, et al.
Publicado: (2022)

The Clinical Impact of Tumor Grade Heterogeneity in Non-muscle-invasive Urothelial Carcinoma of the Bladder
por: CULPAN, Meftun, et al.
Publicado: (2021)

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
por: Kim, Hongsik, et al.
Publicado: (2023)

Role of immunotherapy in localized muscle invasive urothelial cancer
por: Kaur, Jasmeet, et al.
Publicado: (2021)

Epigenetic modification suppresses proliferation, migration and invasion of urothelial cancer cell lines
por: Brockmeyer, Phillipp, et al.
Publicado: (2016)

The miRNome of canine invasive urothelial carcinoma
por: Varvil, Mara S., et al.
Publicado: (2022)

Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
por: Zhang, Shufang, et al.
Publicado: (2014)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder
por: Massari, Francesco, et al.
Publicado: (2015)

Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
por: Baras, Alexander S., et al.
Publicado: (2015)

Urinary laminin‐γ2 is a novel biomarker of non‐muscle invasive urothelial carcinoma
por: Kamada, Masayuki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_88sabf7ne3vef49h41lesipveu